DK3458039T3 - Tripelkombination af rene 5-ht6-receptorantagonister, acetylcholinesterasehæmmere og nmda-receptorantagonist - Google Patents
Tripelkombination af rene 5-ht6-receptorantagonister, acetylcholinesterasehæmmere og nmda-receptorantagonist Download PDFInfo
- Publication number
- DK3458039T3 DK3458039T3 DK16763575.4T DK16763575T DK3458039T3 DK 3458039 T3 DK3458039 T3 DK 3458039T3 DK 16763575 T DK16763575 T DK 16763575T DK 3458039 T3 DK3458039 T3 DK 3458039T3
- Authority
- DK
- Denmark
- Prior art keywords
- pure
- triple combination
- acetylcholine esterase
- esterase inhibitors
- receptor antagonist
- Prior art date
Links
- 108091005435 5-HT6 receptors Proteins 0.000 title 1
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 title 1
- 229940099433 NMDA receptor antagonist Drugs 0.000 title 1
- 239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641017204 | 2016-05-18 | ||
| PCT/IB2016/054672 WO2017199070A1 (en) | 2016-05-18 | 2016-08-03 | Triple combination of pure 5-ht6 receptor antagonists, acetylcholinesterase inhibitors and nmda receptor antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3458039T3 true DK3458039T3 (da) | 2020-09-14 |
Family
ID=56896730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16763575.4T DK3458039T3 (da) | 2016-05-18 | 2016-08-03 | Tripelkombination af rene 5-ht6-receptorantagonister, acetylcholinesterasehæmmere og nmda-receptorantagonist |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US11253514B2 (da) |
| EP (1) | EP3458039B1 (da) |
| JP (1) | JP6629464B2 (da) |
| KR (1) | KR102016120B1 (da) |
| CN (1) | CN109152751A (da) |
| AU (1) | AU2016407426B2 (da) |
| BR (1) | BR112018073410A2 (da) |
| CA (1) | CA3023836C (da) |
| CY (1) | CY1123644T1 (da) |
| DK (1) | DK3458039T3 (da) |
| EA (1) | EA038087B1 (da) |
| ES (1) | ES2815555T3 (da) |
| HK (1) | HK1258022A1 (da) |
| HR (1) | HRP20201412T1 (da) |
| HU (1) | HUE052077T2 (da) |
| IL (1) | IL262920B (da) |
| LT (1) | LT3458039T (da) |
| MA (1) | MA45002B1 (da) |
| MD (1) | MD3458039T2 (da) |
| MX (1) | MX384146B (da) |
| NZ (1) | NZ747797A (da) |
| PL (1) | PL3458039T3 (da) |
| PT (1) | PT3458039T (da) |
| RS (1) | RS60849B1 (da) |
| SG (1) | SG11201809726UA (da) |
| SI (1) | SI3458039T1 (da) |
| SM (1) | SMT202000521T1 (da) |
| WO (1) | WO2017199070A1 (da) |
| ZA (1) | ZA201807310B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL271694B2 (en) * | 2017-07-03 | 2025-01-01 | Suven Life Sciences Ltd | New uses of a pure 5-HT6 receptor antagonist – the compound 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1-hydrogen-indole or its pharmaceutically acceptable salts |
| US20220409614A1 (en) * | 2019-12-02 | 2022-12-29 | Suven Life Sciences Limited | Treating behavioral and psychological symptoms in dementia patients |
| MA57828B1 (fr) * | 2019-12-02 | 2025-09-30 | Suven Life Sciences Limited | Combinaisons du masupirdine avec du donépézil ou de la mémantine pour le traitement de symptômes comportementaux et psychologiques chez des patients atteints de démence |
| CN117024326A (zh) * | 2023-07-26 | 2023-11-10 | 平顶山学院 | 5位氨基取代吲哚化合物及其制备方法和在抗乙酰胆碱酯酶药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1509232B1 (en) * | 2002-05-31 | 2008-11-19 | H. Lundbeck A/S | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| US7875605B2 (en) | 2002-11-28 | 2011-01-25 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| AU2010340745B2 (en) | 2010-01-05 | 2014-11-20 | Suven Life Sciences Limited | Sulfone compounds as 5-HT6 receptor ligands |
| AU2014358682B2 (en) * | 2013-12-02 | 2016-10-20 | Suven Life Sciences Limited | Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate |
| CN105085436B (zh) | 2014-04-19 | 2019-08-16 | 广东东阳光药业有限公司 | 磺酰胺类衍生物及其在药物上的应用 |
-
2016
- 2016-08-03 KR KR1020187035888A patent/KR102016120B1/ko active Active
- 2016-08-03 JP JP2018559327A patent/JP6629464B2/ja active Active
- 2016-08-03 SI SI201630909T patent/SI3458039T1/sl unknown
- 2016-08-03 CA CA3023836A patent/CA3023836C/en active Active
- 2016-08-03 PT PT167635754T patent/PT3458039T/pt unknown
- 2016-08-03 NZ NZ747797A patent/NZ747797A/en unknown
- 2016-08-03 HU HUE16763575A patent/HUE052077T2/hu unknown
- 2016-08-03 RS RS20201045A patent/RS60849B1/sr unknown
- 2016-08-03 MA MA45002A patent/MA45002B1/fr unknown
- 2016-08-03 PL PL16763575T patent/PL3458039T3/pl unknown
- 2016-08-03 DK DK16763575.4T patent/DK3458039T3/da active
- 2016-08-03 SM SM20200521T patent/SMT202000521T1/it unknown
- 2016-08-03 US US16/097,752 patent/US11253514B2/en active Active
- 2016-08-03 SG SG11201809726UA patent/SG11201809726UA/en unknown
- 2016-08-03 WO PCT/IB2016/054672 patent/WO2017199070A1/en not_active Ceased
- 2016-08-03 ES ES16763575T patent/ES2815555T3/es active Active
- 2016-08-03 HK HK19100393.2A patent/HK1258022A1/zh unknown
- 2016-08-03 HR HRP20201412TT patent/HRP20201412T1/hr unknown
- 2016-08-03 AU AU2016407426A patent/AU2016407426B2/en active Active
- 2016-08-03 LT LTEP16763575.4T patent/LT3458039T/lt unknown
- 2016-08-03 BR BR112018073410-1A patent/BR112018073410A2/pt not_active Application Discontinuation
- 2016-08-03 CN CN201680085589.7A patent/CN109152751A/zh active Pending
- 2016-08-03 EA EA201892528A patent/EA038087B1/ru unknown
- 2016-08-03 EP EP16763575.4A patent/EP3458039B1/en active Active
- 2016-08-03 MX MX2018014184A patent/MX384146B/es unknown
- 2016-08-03 MD MDE20190349T patent/MD3458039T2/ro unknown
-
2018
- 2018-10-31 ZA ZA2018/07310A patent/ZA201807310B/en unknown
- 2018-11-11 IL IL262920A patent/IL262920B/en active IP Right Grant
-
2020
- 2020-09-04 CY CY20201100834T patent/CY1123644T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE054804T2 (hu) | Glükokortikoid receptor antagonista és annak immunkonjugátumai | |
| DK3125893T3 (da) | Deutererede heterocyklus-fusionerede gamma-carboliner som antagonister af 5-ht2a-receptorer | |
| DK3233863T3 (da) | Kondenserede ringheteroarylforbindelser og anvendelse deraf som trk-hæmmere | |
| DK3728207T3 (da) | Quinazolinoner som parp14-inhibitorer | |
| DK3601225T3 (da) | Substituerede indolinderivater som inhibitorer af denguevirus-replikation | |
| DK3325490T3 (da) | 1-substituerede 1,2,3,4-tetrahydro-1,7-naphthyridin-8-aminderivater og deres anvendelse som ep4-receptorantagonister | |
| DK3297631T3 (da) | NK-1/NK-3-receptorantagonist til behandling af hedeture | |
| DK3380456T3 (da) | Kompleks af angiotensin receptor antagonist og neutral endopeptidase inhibitor | |
| HUE054542T2 (hu) | Glükokortikoid receptor inhibitor | |
| HUE053958T2 (hu) | Androgén receptor antagonista kristályos formái, elõállítási eljárása és alkalmazása | |
| DK3119783T3 (da) | Inhibitorer af adapter associeret kinase 1, sammensætninger omfattende disse og fremgangsmåde til disses anvendelse | |
| IL262920B (en) | Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and nmda receptor agonist | |
| IL262921B (en) | Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors | |
| ZA201807311B (en) | Combination of pure 5-ht6 receptor antagonists with nmda receptor antagonist | |
| DK3539545T3 (da) | Krystallinsk form af gnrh-receptorantagonist og fremgangsmåde til fremstilling deraf | |
| DK3500306T3 (da) | Tripelkombination af inverse histamin-3-receptoragonister, acetylcholinesterasehæmmere og nmda-receptorantagonist | |
| DK3336088T3 (da) | Krystalform af orexinreceptorantagonistforbindelse, og fremgangsmåde til fremstilling og anvendelse af denne | |
| DK3277278T3 (da) | Kombinationsdoseringsform af en my-opioid receptorantagonist og et opioid | |
| EP3889133A4 (en) | ESTROGEN RECEPTOR ANTAGONIST | |
| DK3518905T3 (da) | Farmaceutiske sammensætninger af 5-ht6-antagonist | |
| DK3245260T3 (da) | Sammensætninger af forstadie til ildfast maling og deres anvendelse | |
| TH1601001484A (th) | สูตรผสมสำหรับ cgrp รีเซปเตอร์แอนตะกอนิสต์ | |
| TH1501006213A (th) | รูปแบบยาของโพรเจสเทอโรนรีเซปเตอร์แอนตะกอนิสต์ |